KALV
KalVista Pharmaceuticals (KALV)
$54
About KalVista Pharmaceuticals (KALV)
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.
Details
Daily high
$11.72
Daily low
$11.45
Price at open
$11.58
52 Week High
$16.88
52 Week Low
$7.21
Market cap
502.6M
Dividend yield
0.00%
Volume
38,871
Avg. volume
545,759
P/E ratio
-3.29
KalVista Pharmaceuticals News
Details
Daily high
$11.72
Daily low
$11.45
Price at open
$11.58
52 Week High
$16.88
52 Week Low
$7.21
Market cap
502.6M
Dividend yield
0.00%
Volume
38,871
Avg. volume
545,759
P/E ratio
-3.29